ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/18/2026
Back to search
Official data from USPTO
SUTORA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SUTORA
ST13
US500000090669914Class
3, 5, 10
Filing
90669914
Registration
7424263
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
02/19/2026
Trademark type
Word
Nice classes
3, 5, 10
Filing date
04/25/2021
Registration date
06/25/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
02/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
DUBLIN, IE
Examiner
ALBANO, ASHLEY C
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Bausch Health Ireland Limited
Representatives
Jeremy Blackowicz Bausch Health Companies
Technical classification
Nice Classes
Class 3Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Non-medicated substances and preparations for the skinmoisturizerscreamsbody powdersgelsshampoosspraysbody washes; Non-medicated dental rinses for oral health
Class 5
Topical antibiotics to treat atopic dermatitisactinic keratosisacnerosaceapsoriasisathlete's footnail fungus and other skin ailmentsconditions and dermatoses; Pharmaceutical preparations and substances for diagnosis and treatment of oral diseaseperiodontitisoral mucousitis and bone and soft tissue regeneration; Medicated dental rinse for oral health; Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipationhepatic encephalopathyirritable bowel syndromeopioidinduced constipation and ulcerative colitis; Medicated beveragespowdersgels for colonoscopies and endoscopic procedures; Pharmaceutical preparations and substances to prevent and treat diabetes mellitusepilepsymigrainesanxiety and depressionchronic painheadachespsychiatric disordersrare diseases in the nature of Wilson and Huntington's diseasediabetes mellituscardiovascular/anginahyperammonaemiahormone deficiencies (endocrinology)cancerotolaryngologyurinary tractlungsheart infections and diseasescentral nervous system disordersneuromuscular conditionsvaginal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of skin and nail conditionsacnepsoriasisonychomycosistinea pedisactinic keratosisrosacea and other dermatosesfungal infections; Vitamins and mineral supplements; Non-medicated dermatologic substances and preparations for the skinointments to treat atopic dermatitisactinic keratosisacnerosaceapsoriasisathlete's footnail fungus and other skin ailmentsconditions and dermatoses; Non-medicated oral health substances preparations in the form of tooth and mouth powderscreamsrinses for the treatment of periodontitismouth drynesscold soresmouth ulcers; Cotton swabs impregnated with non-medicated dermatologic skin care preparations for treating atopic dermatitisactinic keratosisacnerosaceapsoriasisathlete's footnail fungus and other skin ailmentsconditions and dermatoses
Class 10
Radio frequency medical devices for contracting skinbody sculptingsoft tissue reconstruction in a non-invasive manner; Medical devices for aesthetic and therapeutic applications for the skin and its subcutaneous structuresa device for delivering energy to the skin and its underlying tissues; Lasers and radio frequency devices for medical and aesthetic treatment; Medical devicesmedical instruments designed for the non-invasive removal of human body fat using an external energy source
Publications
History of USPTO decisions and trademark events.
59 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/11/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/15/2023
GNRT
NON-FINAL ACTION E-MAILED
12/15/2023
CNRT
NON-FINAL ACTION WRITTEN
12/15/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/06/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/14/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/27/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/17/2023
GNRT
NON-FINAL ACTION E-MAILED
10/17/2023
CNRT
NON-FINAL ACTION WRITTEN
10/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/29/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/29/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/29/2023
ALIE
ASSIGNED TO LIE
08/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/14/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/13/2023
GNRT
NON-FINAL ACTION E-MAILED
04/13/2023
CNRT
NON-FINAL ACTION WRITTEN
04/13/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/18/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/28/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/14/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/22/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/08/2022
GNRT
NON-FINAL ACTION E-MAILED
08/08/2022
CNRT
NON-FINAL ACTION WRITTEN
08/08/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/28/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/28/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/28/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/28/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/07/2022
GNRT
NON-FINAL ACTION E-MAILED
01/07/2022
CNRT
NON-FINAL ACTION WRITTEN
01/07/2022
DOCK
ASSIGNED TO EXAMINER
12/20/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/16/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/16/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/30/2021
NWAP
NEW APPLICATION ENTERED
04/28/2021
Continuous trademark protection
Get notified about every new filing that threatens SUTORA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.